Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This trial tests surgical oophorectomy (removal of ovaries) plus Tamoxifen, done at different
times in the menstrual cycle, as adjuvant therapy for invasive breast cancer in 510
premenopausal women with Hormone Receptor-positive Breast Cancer. This study is recruiting at
hospitals in Philippines, Vietnam, and Morocco.